Free shipping — the threshold depends on the destination country, confirmed at checkout.

    Research Use Only (RUO). For laboratory research only. Not for human or veterinary use.

    Research Use Only (RUO):Research classification with product and batch documentation where available.
    KLOW (GHK-CU 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) 80 mg - Avenor Peptides

    Recovery & Repair

    KLOW (GHK-CU 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg)

    Strength: 80 mg

    For research use only. A blend of four peptides in one vial: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, 80 mg in total.

    €150,10€190,00
    -21% off
    In stock
    1

    The more products, the bigger the discount

    2 → −5%
    3 → −8%
    4 → −11%
    5+ → −15%
    across your whole basket, automatically
    Secure payments
    Batch documentationShips from Greece

    Free shipping: Greece from €50, Cyprus and Bulgaria from €100, France, Germany, Italy, Belgium, Netherlands, Spain, Austria, Czechia, Denmark, Estonia, Finland, Hungary, Ireland, Lithuania, Luxembourg, Latvia, Poland, Portugal, Romania, Sweden and Slovakia from €200. Details

    This product is intended exclusively for laboratory research use. It is not intended for human consumption, diagnosis, treatment, or prevention of disease.

    Product information

    FormResearch product
    Strength80 mg
    SKUAVR-KLOW80MG-80
    Stock statusIn stock
    COA / BatchSee the documentation state below
    Packaging / shippingControlled shipping preparation according to the available SKU variant.

    Documentation on request

    There is no published document for this specific SKU variant at the moment.

    Contact us about documentation

    Research overview

    For research use only. A blend of four peptides in one vial: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, 80 mg in total. Reference details: Recovery & Repair / SKU AVR-KLOW80MG-80.

    Documentation & COA

    Batch documentation and COA, where available, are linked to the specific product batch and SKU.

    This product is intended exclusively for laboratory research use. It is not intended for human consumption, diagnosis, treatment, or prevention of disease.

    Product profile

    4

    peptides in one vial

    80 mg

    total per vial (sum)

    3 + 15 + 43 + 3

    amino acids per component (GHK-Cu, BPC-157, TB-500, KPV)

    Lyophilised powder

    form

    Research context

    What it is

    One vial with four peptides.

    GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg.

    80 mg in total per vial.

    The technical detail

    Lyophilised powder. Values are per vial, as declared by the supplier. 50 + 10 + 10 + 10 = 80 mg.

    What each component is

    GHK-Cu — the tripeptide Gly-His-Lys complexed with copper(II).

    BPC-157 — a synthetic 15-amino-acid peptide.

    TB-500 — a fragment of thymosin beta-4, a 43-amino-acid chain.

    KPV — the tripeptide Lys-Pro-Val.

    The technical detail

    CAS: BPC-157 137525-51-0; thymosin beta-4 77591-33-4. PubChem: GHK CID 73587, GHK-Cu CID 139035031, BPC-157 CID 9941957, thymosin beta-4 CID 45382195, Lys-Pro-Val CID 125672.

    Name and documentation

    “KLOW” is the supplier's trade name.

    This page describes only the identity and declared amount of each component.

    Purity is not stated without a Certificate of Analysis for the specific batch.

    The name does not describe skin appearance or any outcome.

    The technical detail

    The composition comes from the supplier's declaration and is stated in the product name.

    Laboratory use

    Used in a controlled laboratory setting as reference material for identity and content confirmation of the four components. No administration protocol is supplied.

    Research Use Only. For laboratory research exclusively. Not intended for human or veterinary use. The trade name is not a claim of any effect. No therapeutic, diagnostic or dosage claim is made.

    Structural data

    GHK-Cu
    50 mg per vial · copper(II) complex of a tripeptide
    BPC-157
    10 mg per vial · 15-amino-acid peptide
    TB-500
    10 mg per vial · thymosin beta-4 fragment
    KPV
    10 mg per vial · tripeptide Lys-Pro-Val
    Total per vial
    80 mg (sum of declared values)
    GHK-Cu — identity
    Gly-His-Lys complexed with copper(II) · GHK: C14H24N6O4, 340.38 g/mol
    BPC-157 — sequence
    Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
    BPC-157 — identity
    C62H98N16O22 · 1419.5 g/mol · CAS 137525-51-0
    TB-500 — identity
    Thymosin beta-4: 43 amino acids · about 4963 g/mol · CAS 77591-33-4
    KPV — identity
    C16H30N4O4 · 342.43 g/mol
    Form
    Lyophilised powder in a vial
    Category
    Blend of four peptides
    Trade name
    KLOW (supplier's trade name)
    Composition source
    As declared by the supplier

    Documentation

    • Composition as declared by the supplier.
    • Certificate of Analysis (CoA) per batch, where available.
    • Documentation is tied to the specific batch and its SKU.

    References

    References & documentation

    1. 1.PubChem CID 73587 — Gly-His-Lys (GHK, the tripeptide in GHK-Cu).
    2. 2.PubChem CID 139035031 — GHK-Cu (copper complex).
    3. 3.PubChem CID 9941957 — BPC-157.
    4. 4.PubChem CID 45382195 — Thymosin beta-4 (TB-500).
    5. 5.PubChem CID 125672 — Lys-Pro-Val (KPV).

    Product information

    Frequently asked questions

    How many peptides does KLOW contain?
    Four, in one vial: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg.
    What does 80 mg mean?
    It is the sum of the four declared amounts per vial: 50 + 10 + 10 + 10 = 80 mg.
    What does “KLOW” mean?
    It is the trade name under which the supplier sells the blend. It is not a claim of any effect or use.
    Where does the composition come from?
    From the supplier's composition declaration, which is also stated in the product name. Where a Certificate of Analysis is available for the batch, it is linked to the corresponding SKU.

    Explore more

    Related Research Products

    Products from the same research category for quick comparison of documentation, strength and availability.

    View category